Seasonal Malaria chemoprevention: where are we ten years on?

Ten years ago, the World Health Organization (WHO) first recommended the use of antimalarial drugs to prevent severe malaria in children under five in areas with high infection loads and high seasonal transmission of malaria. To mark this ten-year point, L’Initiative has produced a guidance note to outline the fundamental contribution of seasonal malaria chemoprevention (SMC) to reducing malaria mortality in infants and young children, as well as the operational and strategic challenges to be addressed to optimize the impact of SMC in the future.